Biotronik has announced that it will showcase the Lumax 740 ICD and CRT-D series and the Evia HF-T with ProMRI a technology which allows patients requiring tachycardia and heart failure therapies to have access to magnetic resonance imaging at the Heart Rhythm Society’s (HRS) 33rd Annual Scientific Sessions (9–11 May, Boston, USA).
“The Lumax 740 and Evia HF-T series mark an entirely new era of innovation in implantable cardiac device technology,” commented Christoph Böhmer, managing director, Biotronik. “The broad device and lead portfolios of both the Lumax 740 and Evia HF-T series offer physicians the unique opportunity to select the optimal device for each patient, as well as giving their patients access to MR scans.”
Biotronik’s education programmes at the HRS Congress
At Heart Rhythm 2012, Biotronik will support the EPIC Alliance Meeting and the Max Schaldach Research Fellowship in Cardiac Pacing and Electrophysiology. The EPIC Alliance (Electrophysiologist International Community Alliance) supports female physicians and researchers working in the field of electrophysiology and is holding one of its international meetings at the Heart Rhythm Society congress.
The Max Schaldach Fellowship is a US$50,000 postdoctoral Heart Rhythm Society Research Fellowship in cardiac electrophysiology that will be awarded at the congress on 11 May 2012. The goal of the full-year postdoctoral award is to assist awardees in initiating world-class research. The award is presented in the name of professor Max Schaldach, the inventor of the first German pacemaker and founder of Biotronik, to support the research training of individuals in either basic or clinical electrophysiology.
